Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours.
about
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer.Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women's cancers.Olaparib for the treatment of epithelial ovarian cancer.Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Olaparib for the treatment of breast cancer.An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer.
P2860
Q33435557-DEC39778-C485-4156-821F-6E6B7E784D73Q34514973-67A05FFC-526D-44DA-BD73-CAC722F45277Q38683171-9413F11F-F0EB-4085-9638-EEFF74855761Q38747272-08606A01-2EEB-4D7F-95C1-CE93362AFAD0Q38769964-0B3DC038-413A-4A74-8B1B-6B2E4CBF2E64Q38804812-BCCAA65A-FF57-4367-95D6-EBFC4BEE08B7Q38843992-B7BCE940-E047-4640-8EBB-FD9FD41CA3EEQ38881168-8069CBD7-BC15-43F7-9D60-C97400957856Q39461781-023368F2-934B-4AC2-997B-CC79B6D963C5Q42517340-19C9A0A5-E533-4677-B757-025F843F64AC
P2860
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Olaparib tablet formulation: e ...... s with advanced solid tumours.
@en
type
label
Olaparib tablet formulation: e ...... s with advanced solid tumours.
@en
prefLabel
Olaparib tablet formulation: e ...... s with advanced solid tumours.
@en
P2093
P2860
P1476
Olaparib tablet formulation: e ...... ts with advanced solid tumours
@en
P2093
Anitra Fielding
Carla M L van Herpen
Dorte Nielsen
Guy Jerusalem
Helen Swaisland
James Spicer
Karin Leunen
L Rhoda Molife
Martijn P Lolkema
P2860
P2888
P304
P356
10.1007/S00280-015-2836-2
P577
2015-08-05T00:00:00Z
P6179
1043821500